This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 722717.
ESR5: Effects of intravitreal slow controlled release of neurotrophic retinal Müller glial cell (RMC)-derived factors (Germany)
The Institute for Ophthalmic Research at the Eberhard-Karls-Universität Tübingen (EKUT) is headed by Prof. Marius Ueffing and cooperates closely with the University Eye Hospital (Prof. Karl Ulrich Bartz-Schmidt) under the common roof of the Centre for Ophthalmology. Our group focuses on identify pathomechanisms of Retina Degeneration (RD), find genetic and biomarker signatures and develop personalized therapeutic approaches for RD. This last goal includes validation of therapies in animal models and translation into clinical practice.
DOCTORAL STUDENT POSITION (Early Stage Researcher 5: Effects of intravitreal slow controlled release of neurotrophic retinal Müller glial cell (RMC)-derived factors)
We invite applications for a three-year Early Stage Researcher (Ph.D. student) position being part of OCUTHER – European Training Network within Marie Sklodowska Curie Programme Applicants should be self-motivated and able of analytical thinking. A strong interest and background in neurosciences, cell biology, cell signalling or molecular biology is favourable. Proficient communication skills in English as well as organizational skills are required.
The young researcher will gain knowledge in retina structure as well as in cell biology, and will develop various in vivo and in vitro skills essential for validate neuroprotective therapeutic approaches in retina degeneration. The Early Stage Researcher (ESR) will be involved in research on the therapeutic potency of novel neurotrophic factors in vivo and the efficacy of their application using sustained delivery systems. To this end, the ESR will participate in generation of delivery systems to improve intraocular administration and sustained release of neurotrophic peptides, validate RMC-derived neurotrophic peptide efficacy against neuronal cell death in rodent animal models of retinal degeneration, and finally, the ERS will test, optimise and validate intravitreal application of RMC-derived factors using a sustained delivery system.
Highly competitive salary as well as funds to participate in training activities of the OcuTher network as well as in international conferences. The candidate will also enrol in the PhD program of the Graduate Training Center of Neuroscience at Eberhard Karls University Tübingen (http://www.neuroschool-tuebingen.de) for lectures, seminars, and other learning activities.
Please send CV and a letter of intent to Blanca Arango-Gonzalez (email@example.com)
Further information on the OcuTher Initial Training Network can be found at [OcuTher website]
EU RESEARCH FRAMEWORK PROGRAMME
H2020 – Marie Sklodowska Curie Actions
TYPE OF CONTRACT: Temporary (3 years)
Hours per week: 38.5h (100%)
ORGANISATION / INSTITUTE CONTACT DATA
Dr. Blanca Arango-Gonzalez
University Hospital Tübingen, Germany
Centre for Ophthalmology
Institute for Ophthalmic Research
Head: Prof. Dr. Marius Ueffing
D-72076 Tuebingen, Germany
Tel: +49 (0) 7071 2980741
Fax: +49 (0) +49 (0) 7071295777
ENVISAGED JOB STARTING DATE: Spring 2017, negotiable
APPLICATION DEADLINE: February 5th, 2017
HOW TO APPLY: by e-mail to firstname.lastname@example.org
Your application should include (and be limited to) the following attachments:
- Letter of motivation
- Curriculum Vitae
- Brief statement on how you will contribute to this project
REQUIRED EDUCATION LEVEL
DEGREE: Master degree or equivalent
DEGREE FIELD: medical sciences, biological sciences, or similar with an emphasis on neurosciences,
LANGUAGES LEVEL (good)
REQUIRED RESEARCH EXPERIENCE
MAIN RESEARCH FIELD: medical sciences, biological sciences
RESEARCH SUB FIELD: neuroscience or related
YEARS OF RESEARCH EXPERIENCE: at least 2 years
Candidates must not have resided or carried out their main activity in Germany for more than 12 months in the 3 years immediately prior to their recruitment date. The candidate should not possess a doctoral degree and should have less than 4 years of research experience after graduation with a degree allowing to start a Ph.D. thesis.
SKILLS: We are searching for an Early Stage Researcher who is interested (and should have some experience) in neurosciences. Broad knowledge of the visual system or pre‐existing laboratory experience would be of advantage.